Literature DB >> 25948845

Fluoxymesterone-induced gynaecomastia in a patient with childhood aplastic anaemia.

Tom Edward Ngo Lo1, Zillien C Andal2, Frances Lina Lantion-Ang3.   

Abstract

Gynaecomastia is a benign condition characterised by enlargement of the male breast. Drug-induced gynaecomastia merits deep consideration as it may account for as many as 25% of all cases of gynaecomastia in adults. Although the mechanism is not fully clear, some mechanisms include oestrogen-like activities, stimulation of testicular production of oestrogens, inhibition of testosterone synthesis or blockade of androgen action. Anabolic steroids, in particular when used during the pubertal stage, may cause significant irreversible gynaecomastia. We report a case of 28-year-old Filipino man with persistent gynaecomastia from fluoxymesterone used for aplastic anaemia during his prepubertal stage. Hormonal work ups for gynaecomastia all turned out normal, thus isolating the drug as the cause. The patient was unable to undergo breast reconstruction surgery due to haematological contraindications, but eventually referred to psychiatry for counselling. This case will highlight the paradoxical effect of androgenic steroid used during childhood on male breast proliferation during puberty. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25948845      PMCID: PMC4434366          DOI: 10.1136/bcr-2014-207474

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Fluoxymesterone; a new oral androgen.

Authors:  R M BUCKLE
Journal:  Br Med J       Date:  1959-05-30

Review 2.  Gynecomastia.

Authors:  Gretchen Dickson
Journal:  Am Fam Physician       Date:  2012-04-01       Impact factor: 3.292

Review 3.  Androgen abuse in athletes: detection and consequences.

Authors:  Shehzad Basaria
Journal:  J Clin Endocrinol Metab       Date:  2010-02-05       Impact factor: 5.958

4.  A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia.

Authors:  B M Camitta; E D Thomas; D G Nathan; R P Gale; K J Kopecky; J M Rappeport; G Santos; E C Gordon-Smith; R Storb
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

Review 5.  Gynecomastia: physiopathology, evaluation and treatment.

Authors:  Alfredo Carlos Simões Dornellas de Barros; Marcelo de Castro Moura Sampaio
Journal:  Sao Paulo Med J       Date:  2012       Impact factor: 1.044

6.  Treatment of severe aplastic anemia with antilymphocyte globulin and androgens.

Authors:  E Gluckman; A Devergie; A Faille; A J Barrett; M Bonneau; M Boiron; J Bernard
Journal:  Exp Hematol       Date:  1978-09       Impact factor: 3.084

Review 7.  Drug-induced gynecomastia.

Authors:  Ari Eckman; Adrian Dobs
Journal:  Expert Opin Drug Saf       Date:  2008-11       Impact factor: 4.250

Review 8.  Gynecomastia: pathophysiology, evaluation, and management.

Authors:  Ruth E Johnson; M Hassan Murad
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

Review 9.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement.

Authors:  Evanthia Diamanti-Kandarakis; Jean-Pierre Bourguignon; Linda C Giudice; Russ Hauser; Gail S Prins; Ana M Soto; R Thomas Zoeller; Andrea C Gore
Journal:  Endocr Rev       Date:  2009-06       Impact factor: 19.871

10.  Classification and management of gynecomastia: defining the role of ultrasound-assisted liposuction.

Authors:  Rod J Rohrich; Richard Y Ha; Jeffrey M Kenkel; William P Adams
Journal:  Plast Reconstr Surg       Date:  2003-02       Impact factor: 4.730

View more
  2 in total

Review 1.  Medicinal Use of Testosterone and Related Steroids Revisited.

Authors:  Jan Tauchen; Michal Jurášek; Lukáš Huml; Silvie Rimpelová
Journal:  Molecules       Date:  2021-02-15       Impact factor: 4.411

2.  Bilateral Mastectomy as Radical Treatment of Gynecomastia Secondary to Antiretroviral Therapy in a Low-Income Setting: A Case Report.

Authors:  Mario Antunes; Marcella Schiavone; Damiano Pizzol; Francesco Di Gennaro; Rossana Ludovico; Angela De Palma
Journal:  Drug Saf Case Rep       Date:  2018-05-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.